Hugh M Cole's Net Worth

$419 Thousand

Estimate Recalculated Sep 8, 2024 07:39PM EST

Who is Hugh M Cole?

Hugh M Cole does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Jounce Therapeutics, Inc., Astria Therapeutics, Inc., and ARIAD PHARMACEUTICALS INC.

SEC CIK

Hugh M Cole's CIK is 0001604646

Past Insider Trading and Trends

2016 was Hugh M Cole's most active year for acquiring shares with 7 total transactions. Hugh M Cole's most active month to acquire stocks was the month of May. 2016 was Hugh M Cole's most active year for disposing of shares, totalling 7 transactions. Hugh M Cole's most active month to dispose stocks was the month of December. 2021 saw Hugh M Cole paying a total of $689,676.00 for 190,100 shares, this is the most they've acquired in one year. In 2021 Hugh M Cole cashed out on 34,219 shares for a total of $257,942.04, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jounce Therapeutics, Inc. No price found

Chief Operating Officer

Hugh M Cole owns 110,082 units of Common Stock. In the year 2017 Hugh M Cole acquired a total of 167,750 shares in Jounce Therapeutics, Inc. at a cost of $69,646.00, Hugh also disposed a total of 57,668 shares of Jounce Therapeutics, Inc. equalling to $383,023.45.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-13.13%
-16.63K
$1.11
-$18,481.04
110.08K
Jan 9 - Jan 10
Form 4
+18.74%
20K
—
—
126.72K
Aug 1
Form 4/A
—
0
—
—
0
Feb 1
Form 4
+66.18%
42.5K
—
—
106.72K
Feb 1
Form 4
-13.09%
-9.67K
$6.88
-$66,579.65
64.22K
Jan 7 - Jan 10
Form 4
+56.58%
26.7K
—
—
73.89K
Feb 1
Form 4
-14.50%
-8.00K
$8.72
-$160,350.00
47.19K
Scheduled
Jan 22
Form 4
-10.13%
-6.22K
$6.89
-$42,842.04
55.19K
Jan 7 - Jan 8
Form 4
-3.43%
-2.18K
$4.71
-$10,276.44
61.41K
Aug 14 - Aug 18
Form 4
+89.31%
30K
—
—
63.59K
Feb 3
Form 4
-7.25%
-2.62K
$7.78
-$20,414.72
33.59K
Jan 7
Form 4
-6.06%
-2.34K
$3.99
-$9,329.56
36.21K
Aug 14 - Aug 16
Form 4
+136.50%
22.25K
—
—
38.55K
Feb 1
Form 4
+757.89%
14.4K
—
—
16.3K
Aug 13
Form 4
∞
1.9K
$7.84
$14,896.00
1.9K
Jun 15
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found

Astria Therapeutics, Inc. (ATXS) Snapshot price: $11.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 2
Form 4/A
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jul 26
Form 3
—
0
—
—
0
No matching records found

ARIAD PHARMACEUTICALS INC No price found

SVP, Chief Business Officer

Hugh M Cole used to own units in Common Stock but no longer holds any shares there.acquired a total of 63,167 shares in ARIAD PHARMACEUTICALS INC at a cost of $46,575.00, Hugh also disposed a total of 63,167 shares of ARIAD PHARMACEUTICALS INC equalling to $152,280.51.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-42.83K
—
—
0
Feb 16
Form 4
+43.18%
12.92K
$8.69
-$54,303.81
42.83K
Jun 25 - Feb 6
Form 4
+78.48%
13.15K
$7.05
-$42,384.60
29.92K
Jun 27 - Jun 28
Form 4
+231.13%
11.7K
$7.18
-$40,452.12
16.76K
Apr 29
Form 4
∞
5.06K
$6.21
$31,435.02
5.06K
Mar 16
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Apr 29
Form 4
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found